Singapore markets open in 1 hour 1 minute

Telesis Bio, Inc. (TBIO)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
0.3300-0.0236 (-6.67%)
At close: 04:00PM EDT
0.3300 0.00 (0.00%)
After hours: 04:52PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-47,724
-47,724
-48,471
-38,958
-18,010
Depreciation & amortisation
4,102
4,102
2,875
1,574
1,457
Stock-based compensation
3,963
3,963
3,727
1,086
43
Change in working capital
-7,766
-7,766
1,787
-3,037
-20
Accounts receivable
-1,332
-1,332
-2,529
-735
-774
Inventory
-1,825
-1,825
168
-1,462
111
Other working capital
-36,647
-36,647
-43,183
-38,552
-15,585
Other non-cash items
765
765
482
333
706
Net cash provided by operating activities
-34,667
-34,667
-38,715
-36,698
-15,381
Cash flows from investing activities
Investments in property, plant and equipment
-1,980
-1,980
-4,468
-1,854
-204
Acquisitions, net
0
0
-556
-13,186
0
Purchases of investments
-33,775
-33,775
-77,428
0
-
Sales/maturities of investments
29,995
29,995
64,445
0
-
Net cash used for investing activities
-5,744
-5,744
-18,007
-15,040
-204
Cash flows from financing activities
Debt repayment
-15,092
-15,092
-15,079
-5,081
-107
Common stock issued
-
-
0
112,484
0
Other financing activities
-
-
-752
-1,367
-
Net cash used provided by (used for) financing activities
11,565
11,565
4,510
121,081
-96
Net change in cash
-28,849
-28,849
-52,212
69,343
-15,681
Cash at beginning of period
30,594
30,594
82,806
13,463
29,144
Cash at end of period
1,745
1,745
30,594
82,806
13,463
Free cash flow
Operating cash flow
-34,667
-34,667
-38,715
-36,698
-15,381
Capital expenditure
-1,980
-1,980
-4,468
-1,854
-204
Free cash flow
-36,647
-36,647
-43,183
-38,552
-15,585